Loading organizations...
Goodgrower operates as a private investment vehicle, exclusively focusing on the healthcare sector. The firm invests in non-pharmaceutical and non-biotechnology companies across the healthcare value chain. Its flexible strategy tailors investment structures to individual needs, accommodating varied geographies, ownership, development stages, and financial commitments to foster enterprise growth.
Established in 2007, Goodgrower originated as the dedicated healthcare investment arm of the Gallardo Family Group. This creation formalized the family’s deep industry experience, providing a focused vehicle. The initiative leveraged their commitment to the healthcare ecosystem, driving strategic growth and innovation within the sector.
Goodgrower partners with management teams of public and private healthcare companies. The firm’s core vision prioritizes people and patients, aiming for long-term transformation in healthcare services. It actively supports innovative business models and solutions that deliver quantifiable improvements, responding to challenges of global healthcare systems.
Key people at Goodgrower.
Key people at Goodgrower.
Goodgrower has 1 tracked investment across 1 company. The latest tracked deal is $32.0M Series B in Kindbody in July 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2020 | Kindbody | $32.0M Series B | Ellen Hukkelhoven | ACME Capital, Brainchild, Distributed Ventures, GV, Erel Margalit, KRM Interests LLC, RRE Ventures, SuperAngel.Fund, Upfront Ventures, VSC Ventures, Baron Davis, Demi Lovato, Shervin Pishevar, Claritas Capital, Freemark Capital, NFP, Rock Springs Capital |